UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

Annals of the rheumatic diseases, 2009-07, Vol.68 (7), p.1086-1093

2009

Volltextzugriff (PDF)

The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers

Rheumatology (Oxford, England), 2015-06, Vol.54 (6), p.1074-1079

2015

Volltextzugriff (PDF)

Interleukin-6 as a key player in systemic inflammation and joint destruction

Autoimmunity reviews, 2009-06, Vol.8 (7), p.538-542

2009

Volltextzugriff (PDF)

AB0954 A New Ultrasonography Protocol for The Assessment of Primary Knee Osteoarthritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1227-1228

2016

Volltextzugriff (PDF)

Alterations on peripheral blood B-cell subpopulations in very early arthritis patients

Rheumatology (Oxford, England), 2010-06, Vol.49 (6), p.1082-1092

2010

Volltextzugriff (PDF)

FRI0070 Trajectories of Disease Activity in Rheumatoid Arthritis Patients after Abatacept Initiation and Their Association with Clinical Characteristics

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.451-452

2016

Volltextzugriff (PDF)

Brief Report: Association of Rheumatoid Factor and Anti–Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan‐European Registry Analysis

Arthritis & rheumatology (Hoboken, N.J.), 2016-06, Vol.68 (6), p.1346-1352

2016

Volltextzugriff (PDF)

Osteoimmunology — The hidden immune regulation of bone

Autoimmunity reviews, 2009-01, Vol.8 (3), p.250-255

2009

Volltextzugriff (PDF)

FRI0187 Rituximab Done! What's Next in Rheumatoid Arthritis? A European Observational Longitudinal Study Assessing the Effectiveness of Biologics After Rituximab Treatment in Rheumatoid Arthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.492-492

2015

Volltextzugriff (PDF)

Bone histomorphometry revisited

Acta reumatológica portuguesa, 2012-10, Vol.37 (4), p.294

2012

Volltextzugriff (PDF)

FRI0139 Serologic Profile and Reactivation of Hepatitis B in Rheumatic and Inflammatory Bowel Disease Patients Treated with Biologic Therapies

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.471-472

2015

Volltextzugriff (PDF)

Effect of Comedication With Conventional Synthetic Disease‐Modifying Antirheumatic Drugs on Retention of Tumor Necrosis Factor Inhibitors in Patients With Spondyloarthritis: A Prospective Cohort Study

Arthritis & rheumatology (Hoboken, N.J.), 2016-11, Vol.68 (11), p.2671-2679

2016

Volltextzugriff (PDF)

SAT0036 Retention of Tocilizumab Therapy: A Comparison between Tocilizumab in Monotherapy and in Combination with DMARDS Based on the Tocerra Collaboration

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.601-602

2014

Volltextzugriff (PDF)

FRI0428 The Weaker Sex: Characterization of Gender Disparities in A Nationwide Lupus Registry (REUMA.PT LES)

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.542

2014

Volltextzugriff (PDF)

OP0031 Tocilizumab is Associated with Higher CDai/Sdai Remission in Biologic-Naïve Rheumatoid Arthritis Patients – Data from Reuma.Pt

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.71

2014

Volltextzugriff (PDF)

AB0451 Changes in DAS28, CDAI and SDAI are Associated with Biologic Class, Gender, Previous Biologic Therapy and ACPA/RF Status – Results from Reuma.PT

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.957-957

2014

Volltextzugriff (PDF)

AB0413 Hepatitis B Serologic Profile and Reactivation in Rheumatic Patients Treated with Biological Therapies – Single Centre Experience

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.943-944

2014

Volltextzugriff (PDF)

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

Annals of the rheumatic diseases, 2017-02, Vol.76 (2), p.386-391

2017

Volltextzugriff (PDF)

Delayed neutrophil apoptosis in very early rheumatoid arthritis patients is abrogated by methotrexate therapy

Clinical and experimental rheumatology, 2007-11, Vol.25 (6), p.885

2007

Volltextzugriff (PDF)

Multimorbidity and intention to retire: a cross-sectional study on 14 European countries

International journal of public health, 2020-03, Vol.65 (2), p.187-195

2020

Volltextzugriff (PDF)

THU0086 Seropositivity and response to RTX: Data from the cererra collaboration

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.182-182

2013

Volltextzugriff (PDF)

OP0028 Efficacy of different doses of rituximab for the treatment of RA: Data from the cererra collaboration

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.62-62

2013

Volltextzugriff (PDF)

Characterization of damage in Portuguese lupus patients: analysis of a national lupus registry

Lupus, 2015-03, Vol.24 (3), p.256-262

2015

Volltextzugriff (PDF)

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project

Annals of the rheumatic diseases, 2017-12, Vol.76 (12), p.2025-2030

2017

Volltextzugriff (PDF)

1 – 25 von 300

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(279)
Mit Volltextzugriff
(243)

Publikationsform

Artikel
(269)
Tagungsberichte
(31)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(86)
Life Sciences & Biomedicine
(77)
Humans
(75)
Rheumatology
(68)
Female
(50)
Male
(46)
Medicin Och Hälsovetenskap
(43)
Rheumatoid Arthritis
(40)
Middle Aged
(33)
Aged
(25)
Adult
(24)
Arthritis
(16)
Internal Medicine
(16)
Risk Factors
(16)
Patients
(14)
Arthritis, Rheumatoid - Drug Therapy
(13)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Treatment Outcome
(13)
Portugal
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers

Interleukin-6 as a key player in systemic inflammation and joint destruction

AB0954 A New Ultrasonography Protocol for The Assessment of Primary Knee Osteoarthritis

Alterations on peripheral blood B-cell subpopulations in very early arthritis patients

FRI0070 Trajectories of Disease Activity in Rheumatoid Arthritis Patients after Abatacept Initiation and Their Association with Clinical Characteristics

Brief Report: Association of Rheumatoid Factor and Anti–Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan‐European Registry Analysis

Osteoimmunology — The hidden immune regulation of bone

FRI0187 Rituximab Done! What's Next in Rheumatoid Arthritis? A European Observational Longitudinal Study Assessing the Effectiveness of Biologics After Rituximab Treatment in Rheumatoid Arthritis

Bone histomorphometry revisited

FRI0139 Serologic Profile and Reactivation of Hepatitis B in Rheumatic and Inflammatory Bowel Disease Patients Treated with Biologic Therapies

Effect of Comedication With Conventional Synthetic Disease‐Modifying Antirheumatic Drugs on Retention of Tumor Necrosis Factor Inhibitors in Patients With Spondyloarthritis: A Prospective Cohort Study

SAT0036 Retention of Tocilizumab Therapy: A Comparison between Tocilizumab in Monotherapy and in Combination with DMARDS Based on the Tocerra Collaboration

Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

FRI0428 The Weaker Sex: Characterization of Gender Disparities in A Nationwide Lupus Registry (REUMA.PT LES)

OP0031 Tocilizumab is Associated with Higher CDai/Sdai Remission in Biologic-Naïve Rheumatoid Arthritis Patients – Data from Reuma.Pt

AB0451 Changes in DAS28, CDAI and SDAI are Associated with Biologic Class, Gender, Previous Biologic Therapy and ACPA/RF Status – Results from Reuma.PT

AB0413 Hepatitis B Serologic Profile and Reactivation in Rheumatic Patients Treated with Biological Therapies – Single Centre Experience

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

Delayed neutrophil apoptosis in very early rheumatoid arthritis patients is abrogated by methotrexate therapy

Multimorbidity and intention to retire: a cross-sectional study on 14 European countries

THU0086 Seropositivity and response to RTX: Data from the cererra collaboration

OP0028 Efficacy of different doses of rituximab for the treatment of RA: Data from the cererra collaboration

Characterization of damage in Portuguese lupus patients: analysis of a national lupus registry

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project

Suchergebnisse filtern